中国丙型病毒性肝炎医院感染防控指南(2021年版)

Chinese guideline for the prevention and control of hepatitis C virus healthcare-associated infection (2021 edition)

摘要:

丙型病毒性肝炎是严重威胁人民健康的公共卫生问题。目前尚无预防丙型肝炎病毒（HCV）的疫苗，但直接抗病毒药物联合治疗可以治愈95%以上的慢性丙型病毒性肝炎。加强HCV感染者的筛查，针对确诊HCV感染者尽早进行有效的治疗，是消除传染源，阻断HCV传播的有效措施。本指南在2012年版《中国丙型病毒性肝炎医院感染防控指南》基础上进行修订和更新，主要内容包括丙型病毒性肝炎流行病学及医院感染现状，HCV感染的实验室检测方法与临床意义，以及医院感染防控措施等，为预防和控制丙型病毒性肝炎医院感染提供帮助。

Abstract:

Hepatitis C is a serious public health issue threatening people's health. At present, there is no vaccine to prevent hepatitis C virus (HCV), but combination treatment of direct antiviral drug can cure more than 95% of chronic hepatitis C. Strengthening the screening of HCV-infected person and conducting effective treatment as early as possible is an effective measure to eliminate the source of infection and block the transmission of HCV. This guideline is revised and updated on the basis of 2012 edition of Chinese guideline for the prevention and control of healthcare-associated infection of hepatitis C, which mainly includes the epidemiology and current situation of healthcare-associated infection of hepatitis C, laboratory detection methods and clinical significance of HCV infection, as well as prevention and control measures of healthcare-associated infection, so as to provide help for the prevention of hepatitis C healthcare-associated infection.